Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index; 24 of the 38 sources its claims cite were checked for support.

Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity

Open access

Abstract

Aims/hypothesis: Mitochondria operate in networks, adapting to external stresses and changes in cellular metabolic demand and are subject to various quality control mechanisms. On the basis of these traits, we here hypothesise that the regulation of mitochondrial networks in skeletal muscle is hampered in humans with compromised oxidative capacity and insulin sensitivity. Methods: In a cross-sectional design, we compared four groups of participants (selected from previous studies) ranging in aerobic capacity and insulin sensitivity, i.e. participants with type 2 diabetes ( n = 11), obese participants without diabetes ( n = 12), lean individuals ( n = 10) and endurance-trained athletes ( n = 12); basal, overnight fasted muscle biopsies were newly analysed for the current study and we compared the levels of essential mitochondrial dynamics and quality control regulatory proteins in skeletal muscle tissue. Results: Type 2 diabetes patients and obese participants were older than lean participants and athletes (58.6 ± 4.0 and 56.7 ± 7.2 vs 21.8 ± 2.5 and 25.1 ± 4.3 years, p < 0.001, respectively) and displayed a higher BMI (32.4 ± 3.7 and 31.0 ± 3.7 vs 22.1 ± 1.8 and 21.0 ± 1.5 kg/m 2 , p < 0.001, respectively) than lean individuals and endurance-trained athletes. Fission protein 1 (FIS1) and optic atrophy protein 1 (OPA1) protein content was highest in muscle from athletes and lowest in participants with type 2 diabetes and obesity, respectively (FIS1: 1.86 ± 0.79 vs 0.79 ± 0.51 AU, p = 0.002; and OPA1: 1.55 ± 0.64 vs 0.76 ± 0.52 AU, p = 0.014), which coincided with mitochondrial network fragmentation in individuals with type 2 diabetes, as assessed by confocal microscopy in a subset of type 2 diabetes patients vs endurance-trained athletes ( n = 6). Furthermore, lean individuals and athletes displayed a mitonuclear protein balance that was different from obese participants and those with type 2 diabetes. Mitonuclear protein balance also associated with heat shock protein 60 (HSP60) protein levels, which were higher in athletes when compared with participants with obesity ( p = 0.048) and type 2 diabetes ( p = 0.002), indicative for activation of the mitochondrial unfolded protein response. Finally, OPA1, FIS1 and HSP60 correlated positively with aerobic capacity ( r = 0.48, p = 0.0001; r = 0.55, p < 0.001 and r = 0.61, p < 0.0001, respectively) and insulin sensitivity ( r = 0.40, p = 0.008; r = 0.44, p = 0.003 and r = 0.48, p = 0.001, respectively). Conclusions/interpretation: Collectively, our data suggest that mitochondrial dynamics and quality control in skeletal muscle are linked to oxidative capacity in humans, which may play a role in the maintenance of muscle insulin sensitivity. Clinical Trial registry: numbers NCT00943059, NCT01298375 and NL1888

Overview

CoChat Summary

TL;DR

In a cross-sectional comparison of human skeletal muscle, mitochondrial dynamics and quality-control proteins differed across metabolic health groups, with endurance-trained athletes generally showing the highest OPA1, FIS1 and HSP60 levels and type 2 diabetes patients showing a more fragmented mitochondrial network. OPA1, FIS1 and HSP60 positively correlated with aerobic capacity and insulin sensitivity.

Key findings

  • OPA1 protein content was highest in endurance-trained athletes and lowest in obese non-diabetic participants (1.55 ± 0.64 vs 0.76 ± 0.52 AU, p = 0.014), while FIS1 was highest in athletes and significantly higher than in type 2 diabetes patients (1.86 ± 0.79 vs 0.79 ± 0.51 AU, p = 0.002) and lean participants (1.86 ± 0.79 vs 1.08 ± 0.46 AU, p = 0.04).
  • Confocal imaging in a subset of 6 type 2 diabetes patients vs 6 endurance-trained athletes showed a more fragmented mitochondrial network with more isolated, circular mitochondria in type 2 diabetes, especially in type I fibres.
  • Mitonuclear protein balance (COX4I1/COX II) differed between lean individuals and athletes vs obese and type 2 diabetic participants, and HSP60 was higher in athletes than in obese participants (p = 0.048) and type 2 diabetes patients (p = 0.002).
  • OPA1, FIS1 and HSP60 positively correlated with aerobic capacity (r = 0.48, p = 0.0001; r = 0.55, p < 0.001; r = 0.61, p < 0.0001, respectively) and insulin sensitivity (r = 0.40, p = 0.008; r = 0.44, p = 0.003; r = 0.48, p = 0.001, respectively).

Methods

  • Cross-sectional study of 45 male participants selected from previous studies: type 2 diabetes (n = 11), obese without diabetes (n = 12), lean (n = 10) and endurance-trained athletes (n = 12); basal overnight-fasted vastus lateralis muscle biopsies were newly analysed.
  • Protein content of mitochondrial dynamics and quality-control regulators was measured by western blot; mitochondrial network morphology was assessed by confocal microscopy in a subset of 6 type 2 diabetes patients vs 6 athletes selected by lowest and highest glucose infusion rate.
  • Group comparisons used one-way ANOVA with Tukey’s multiple comparisons test; relationships with metabolic variables were assessed using Pearson correlation analysis.

Limitations

  • Stated: groups differed in age and BMI, making contributions of age and BMI difficult to delineate; imaging was limited to 6 individuals per group at the extreme ends of the metabolic spectrum; protein expression was normalised to total protein rather than mitochondrial protein; mitochondrial content estimates via VDAC1/OXPHOS may be less accurate than electron microscopy or mtDNA copy number.
  • Stated: the data mainly indicate that endurance-trained individuals differ from all other groups, while lean, obese and type 2 diabetic participants often had similar values.
  • Evident from the text: the study is cross-sectional and cannot establish causality; all participants were male, limiting generalisability.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s00125-020-05335-w

Cites

47 of 47 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Graphical abstract
Graphical abstractCC BY · PubMed Central
Fig. 1 Type 2 diabetic individuals show lower expression of proteins involved in mitochondrial dynamics. Representative western blots (a) and associated quantifications (b–f) of mitochondrial dynamics regulatory proteins (MFN1, MFN2, OPA1, DRP1 and FIS1) in human skeletal muscle biopsies. T2DM, participants with type 2 diabetes (n = 11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are normalised to Revert staining and expressed as mean ± SD. *p<0.05, **p<0.01
Fig. 1 Type 2 diabetic individuals show lower expression of proteins involved in mitochondrial dynamics. Representative western blots (a) and associated quantifications (b–f) of mitochondrial dynamics regulatory proteins (MFN1, MFN2, OPA1, DRP1 and FIS1) in human skeletal muscle biopsies. T2DM, participants with type 2 diabetes (n = 11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are normalised to Revert staining and expressed as mean ± SD. *p<0.05, **p<0.01CC BY · PubMed Central
Fig. 2 Type 2 diabetic individuals display a more fragmented skeletal muscle mitochondrial network. Representative confocal images of the mitochondrial network in type I muscle fibres. The cellular membrane was stained in green using laminin as a marker, in red the mitochondrial network is visualised using TOMM20 as a marker. In the overview images (a, b and e, f) scale bar, 20 μm; in the zoomed images (c, d and g, h) scale bar, 5 μm. (a–d) Representative overview and zoomed images of two separate individuals with type 2 diabetes. (e–h) Representative overview and zoomed images of two individual trained athletes. Note the longitudinal pattern of interconnected mitochondria alongside the myofibrils (yellow arrows) and the cross-striated pattern reflecting mitochondria near the Z-line (blue arrows) in the athletes whereas this pattern is virtually absent in the type 2 diabetic participants and the networks present a more punctate dot-like pattern, reflecting disconnected mitochondria
Fig. 2 Type 2 diabetic individuals display a more fragmented skeletal muscle mitochondrial network. Representative confocal images of the mitochondrial network in type I muscle fibres. The cellular membrane was stained in green using laminin as a marker, in red the mitochondrial network is visualised using TOMM20 as a marker. In the overview images (a, b and e, f) scale bar, 20 μm; in the zoomed images (c, d and g, h) scale bar, 5 μm. (a–d) Representative overview and zoomed images of two separate individuals with type 2 diabetes. (e–h) Representative overview and zoomed images of two individual trained athletes. Note the longitudinal pattern of interconnected mitochondria alongside the myofibrils (yellow arrows) and the cross-striated pattern reflecting mitochondria near the Z-line (blue arrows) in the athletes whereas this pattern is virtually absent in the type 2 diabetic participants and the networks present a more punctate dot-like pattern, reflecting disconnected mitochondriaCC BY · PubMed Central
Fig. 3 Type 2 diabetic individuals show lower mitochondrial content. Representative blots (a) and associated quantifications (b–g) of mitochondrial density markers VDAC1 and OXPHOS complex I (CI-NDUFB8), complex II (CII-SDHB), complex III (CIII-UQCRC2), complex IV (CIV-COX II) and complex V (CV-ATP5A) in human skeletal muscle. T2DM, participants with type 2 diabetes (n=11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are normalised to Revert staining and expressed as mean ± SD. OXPHOS complexes are expressed as fold change, with T2DM set to 1. *p<0.05, **p<0.01, ***p<0.001
Fig. 3 Type 2 diabetic individuals show lower mitochondrial content. Representative blots (a) and associated quantifications (b–g) of mitochondrial density markers VDAC1 and OXPHOS complex I (CI-NDUFB8), complex II (CII-SDHB), complex III (CIII-UQCRC2), complex IV (CIV-COX II) and complex V (CV-ATP5A) in human skeletal muscle. T2DM, participants with type 2 diabetes (n=11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are normalised to Revert staining and expressed as mean ± SD. OXPHOS complexes are expressed as fold change, with T2DM set to 1. *p<0.05, **p<0.01, ***p<0.001CC BY · PubMed Central
Fig. 4 Mitonuclear protein balance differs in lean individuals and athletes vs obese and type 2 diabetic participants. Representative blots (a) and associated quantifications of (b) the nuclear-encoded complex IV (CIV) subunit COX4I1, (c) the mtDNA-encoded complex IV subunit COX II and (d) mitonuclear protein balance (COX4I1/COX II) in human skeletal muscle. Both COX4I1 and COX II were detected on the same blots. T2DM, participants with type 2 diabetes (n=11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are expressed as mean fold change ± SD, with T2DM set to 1. *p<0.05, **p<0.01, ***p<0.001, †p=0.06
Fig. 4 Mitonuclear protein balance differs in lean individuals and athletes vs obese and type 2 diabetic participants. Representative blots (a) and associated quantifications of (b) the nuclear-encoded complex IV (CIV) subunit COX4I1, (c) the mtDNA-encoded complex IV subunit COX II and (d) mitonuclear protein balance (COX4I1/COX II) in human skeletal muscle. Both COX4I1 and COX II were detected on the same blots. T2DM, participants with type 2 diabetes (n=11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are expressed as mean fold change ± SD, with T2DM set to 1. *p<0.05, **p<0.01, ***p<0.001, †p=0.06CC BY · PubMed Central
Fig. 5 Endurance-trained athletes show highest protein levels of the mitochondrial chaperone HSP60. Representative western blot analysis (a) and quantification of (b) mitochondrial chaperone HSP60 and (d, e) mito-/autophagy-related proteins in human skeletal muscle biopsies. (c) Mitonuclear protein balance (COX4I1/COX II) is associated with HSP60 protein levels. T2DM, participants with type 2 diabetes (n=11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are normalised to Revert staining and expressed as mean ± SD. *p<0.05, **p<0.01. Correlations are computed with Pearson’s r
Fig. 5 Endurance-trained athletes show highest protein levels of the mitochondrial chaperone HSP60. Representative western blot analysis (a) and quantification of (b) mitochondrial chaperone HSP60 and (d, e) mito-/autophagy-related proteins in human skeletal muscle biopsies. (c) Mitonuclear protein balance (COX4I1/COX II) is associated with HSP60 protein levels. T2DM, participants with type 2 diabetes (n=11); O, obese individuals without type 2 diabetes (n=12); L, lean individuals (n=10); A, endurance-trained athletes (n=12). Values are normalised to Revert staining and expressed as mean ± SD. *p<0.05, **p<0.01. Correlations are computed with Pearson’s rCC BY · PubMed Central
Fig. 6 Proteins involved in mitochondrial dynamics and quality control positively correlate with metabolic variables in human skeletal muscle. Association between protein expression levels of OPA1, FIS1 and HSP60, normalised to Revert staining, with V˙O2max (a–c) and insulin sensitivity (d–f). Correlations are computed with Pearson’s r
Fig. 6 Proteins involved in mitochondrial dynamics and quality control positively correlate with metabolic variables in human skeletal muscle. Association between protein expression levels of OPA1, FIS1 and HSP60, normalised to Revert staining, with V˙O2max (a–c) and insulin sensitivity (d–f). Correlations are computed with Pearson’s rCC BY · PubMed Central

Verification

Claims the paper makes

16 Valid · 0 Not valid · 6 Not checked · 73 Own results and interpretations

49 more claims

Create a free account to see all 95 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 24

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 47 references

Cited by

See all 83

Metadata

Authors
Houzelle, A., Jörgensen, J. A., Schaart, G., Daemen, S., van Polanen, N., Fealy, C. E., Hesselink, M. K. C., Schrauwen, P., & Hoeks, J.
Affiliations
Maastricht University Medical Centre (NL)
Venue
Diabetologia
Published
2020-11-30
Volume
64
Issue
2
Pages
424-436
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3109447570
Cited by
83
References
47
Citations by year
2026: 12 · 2025: 18 · 2024: 12 · 2023: 17 · 2022: 16 · 2021: 8
FWCI
3.32
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion, cc-by)
  • Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders
  • Diabetes Fonds (2013.82.1639)
  • ZonMw (917.14.358)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
mitochondrial dynamics, skeletal muscle, oxidative capacity, insulin sensitivity, type 2 diabetes, obesity, endurance athletes, Fis1, OPA1, HSP60, mitochondrial unfolded protein response, mitochondrial fission, mitochondrial fusion, cardiorespiratory fitness, mitochondrial quality control, mitochondrial fragmentation, heat shock proteins, mitochondrial biogenesis, skeletal muscle mitochondria
MeSH terms
Adult, Biopsy, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Membrane Proteins, Middle Aged, Mitochondria, Muscle, Obesity, Oxidation-Reduction, Oxygen Consumption, Case-Control Studies, Muscle, Skeletal, Chaperonin 60, GTP Phosphohydrolases, Mitochondrial Proteins, Young Adult, Athletes, Mitochondrial Dynamics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity. https://app.cochat.ai/papers/10.1007/s00125-020-05335-w
The paper
Houzelle, A., Jörgensen, J. A., Schaart, G., Daemen, S., van Polanen, N., Fealy, C. E., Hesselink, M. K. C., Schrauwen, P., & Hoeks, J. (2021). Human skeletal muscle mitochondrial dynamics in relation to oxidative capacity and insulin sensitivity. Diabetologia. https://doi.org/10.1007/s00125-020-05335-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.